Director at Veracyte (VCYT) receives grant of 5,272 restricted stock units

Rhea-AI Filing Summary

EASTHAM KARIN reported acquisition or exercise transactions in this Form 4 filing.

VERACYTE, INC. director Karin Eastham received a grant of 5,272 shares of common stock in the form of restricted stock units. These units were awarded at no cash cost and increase her direct holdings to 18,826 shares following the transaction.

The restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the grant date, or immediately before Veracyte’s next annual stockholder meeting if that occurs earlier. They also vest in full if there is a change in control of the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider EASTHAM KARIN

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,272	$0.00	--

Holdings After Transaction: Common Stock — 18,826 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 5,272 shares Price per share: $0.00 per share Shares after transaction: 18,826 shares

3 metrics

RSUs granted 5,272 shares Restricted stock units awarded on June 11, 2026

Price per share $0.00 per share Reported transaction price for RSU grant

Shares after transaction 18,826 shares Total direct holdings following the award

Key Terms

Restricted stock units, change in control, annual meeting of stockholders

3 terms

Restricted stock units financial

"Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

change in control financial

"the restricted stock units vest in full in the event of a change in control of the Issuer"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

annual meeting of stockholders financial

"vest in full on the first anniversary ... or immediately prior to the Company's next annual meeting of stockholders"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

EASTHAM KARIN

(Last) (First) (Middle)

6000 SHORELINE COURT

SUITE 300

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A(1)		5,272	A	$0	18,826	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

Remarks:

	/s/ Jonathan Wygant, as attorney-in-fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Veracyte (VCYT) report for director Karin Eastham?

Veracyte reported that director Karin Eastham received 5,272 restricted stock units of common stock. The award was recorded as an acquisition at no cash cost and represents routine equity-based director compensation, increasing her direct holdings to 18,826 shares after the grant.

How many Veracyte (VCYT) shares does Karin Eastham hold after this Form 4 filing?

After this award, Karin Eastham directly holds 18,826 shares of Veracyte common stock. This figure includes the 5,272 restricted stock units granted on June 11, 2026, as disclosed, and reflects her total direct ownership reported in the Form 4.

What are the vesting terms of Karin Eastham’s new Veracyte (VCYT) restricted stock units?

The 5,272 restricted stock units vest in full on the first anniversary of the June 11, 2026 grant date. They may also vest earlier, immediately before Veracyte’s next annual stockholder meeting, and fully accelerate upon a change in control of the company.

Was cash paid for the Veracyte (VCYT) restricted stock units granted to Karin Eastham?

No cash was paid for this award; the reported price per share is $0.00. The 5,272 restricted stock units were granted as equity compensation, representing a non-cash acquisition that increases her direct position in Veracyte common stock.

How is the Veracyte (VCYT) Form 4 transaction coded and what does it mean?

The transaction is coded “A” for a grant, award, or other acquisition of non-derivative common stock. It represents restricted stock units awarded to director Karin Eastham as compensation, not an open-market share purchase or sale.